Intended for healthcare professionals


Cost effectiveness of multiple sclerosis drugs remains unknown

BMJ 2000; 321 doi: (Published 12 August 2000) Cite this as: BMJ 2000;321:399
  1. Rhona MacDonald
  1. BMJ

    No single drug used in the treatment of multiple sclerosis has been shown to be better than any other despite the huge differences in cost, a recent review has found. Drugs range in annual cost from £18 ($27) (for methotrexate) to £20 000 …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription